dc.contributor.authors |
Turkoglu, EB; Celik, E; Aksoy, N; Bursali, O; Ucak, T; Alagoz, G; |
|
dc.date.accessioned |
2020-01-17T11:59:12Z |
|
dc.date.available |
2020-01-17T11:59:12Z |
|
dc.date.issued |
2015 |
|
dc.identifier.citation |
Turkoglu, EB; Celik, E; Aksoy, N; Bursali, O; Ucak, T; Alagoz, G; (2015). Changes in vision related quality of life in patients with diabetic macular edema: Ranibizumab or laser treatment?. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 29, 543-540 |
|
dc.identifier.issn |
1056-8727 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/6976 |
|
dc.identifier.uri |
https://doi.org/10.1016/j.jdiacomp.2015.03.009 |
|
dc.description.abstract |
Conclusion: Our study revealed that IVR improved not only visual acuity or CRT, but also vision related quality of life more than laser treatment in DME. And these patient-reported outcomes may play an important role in the treatment choice in DME for clinicians. (C) 2015 Elsevier Inc. All rights reserved. |
|
dc.language |
English |
|
dc.publisher |
ELSEVIER SCIENCE INC |
|
dc.subject |
Endocrinology & Metabolism |
|
dc.title |
Changes in vision related quality of life in patients with diabetic macular edema: Ranibizumab or laser treatment? |
|
dc.type |
Article |
|
dc.identifier.volume |
29 |
|
dc.identifier.startpage |
540 |
|
dc.identifier.endpage |
543 |
|
dc.contributor.department |
Sakarya Uygulamalı Bilimler Üniversitesi/Sapanca Meslek Yüksekokulu |
|
dc.contributor.saüauthor |
Çelik, Esra |
|
dc.contributor.saüauthor |
Alagöz, Gürsoy |
|
dc.relation.journal |
JOURNAL OF DIABETES AND ITS COMPLICATIONS |
|
dc.identifier.wos |
WOS:000354157700014 |
|
dc.identifier.doi |
10.1016/j.jdiacomp.2015.03.009 |
|
dc.identifier.eissn |
1873-460X |
|
dc.contributor.author |
Elif Betul Turkoglu |
|
dc.contributor.author |
Çelik, Esra |
|
dc.contributor.author |
Nilgun Aksoy |
|
dc.contributor.author |
Ozlem Bursali |
|
dc.contributor.author |
Turgay Ucak |
|
dc.contributor.author |
Alagöz, Gürsoy |
|